Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Sana Biotechnology Inc (SANA) vs Clear Secure Inc (YOU) Price & Performance

Sana Biotechnology IncTrade
Clear Secure IncTrade

Price performance (Past 24H)

Key statistics

Sana Biotechnology Inc vs Clear Secure Inc — how do they compare? Sana Biotechnology Inc trades at $3.17 (market cap $873.84M), while Clear Secure Inc trades at $57.03 (market cap $5.76B). The key difference: Clear Secure Inc is far larger — about 6.6× Sana Biotechnology Inc's market cap, and Clear Secure Inc pays a 1.05% dividend while Sana Biotechnology Inc pays none. Which is the better fit depends on your goals.

SANAYOU
Market Cap
$873.84M$5.76B
Sector
HealthTechnology
52-Week High
$5.92$62.36
52-Week Low
$2.68$28.84
Enterprise Value
$848.03M$5.07B
Dividend Yield
1.05%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Sana Biotechnology Inc

SANA Biotechnology trades at $3.14, down 0.32% with bearish technical indicators despite strong analyst support. The company shows significant financial challenges with negative ROE of -147.41% and net income of -$244.17M for 2025, though cash burn improved from -$55M to -$12M in 2026. Recent positive developments include a Zacks upgrade to Buy and groundbreaking clinical data published in NEJM.

Investment outlook remains speculative with high execution risk given substantial losses, but strong analyst consensus (82% Buy ratings) reflects optimism about SANA's innovative cell therapy pipeline. Key risks include continued cash burn and clinical trial outcomes, while potential catalysts include successful product development in diabetes and CAR-T therapies.

Clear Secure Inc

Clear Secure (YOU) trades at $57.18, up 2.05% with strong technical momentum and bullish moving average signals. The company demonstrates robust fundamentals with 65.48% gross margins and impressive 81.15% ROE, though valuation multiples remain elevated with a P/E of 44.82. Recent earnings beat expectations in Q1 2026 with $0.38 EPS versus $0.35 expected, while analyst sentiment remains divided with equal buy/hold ratings.

The stock presents growth potential with expanding revenue and profitability, but faces valuation concerns and competitive pressures. Key catalysts include continued airport expansion and AWS partnership, while risks involve execution challenges and market volatility. The consensus price target of $56.67 suggests limited near-term upside from current levels.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Sana Biotechnology Inc

Sana Biotechnology Inc. is a clinical-stage biopharmaceutical company focused on creating and delivering engineered cells as medicines for patients. The company is developing cell therapies for various diseases, including oncology, diabetes, and central nervous system disorders. Sana's core strategy is built around two key technological platforms: in vivo gene delivery to repair cells inside the body and ex vivo cell engineering for therapeutic use.

Read more on SANA

About Clear Secure Inc

Clear Secure operates a secure identity platform that uses biometrics—specifically eyes, face, and fingerprints—to automate and expedite identity verification. While its most visible application is the CLEAR Plus airport subscription service, the company functions as a broad-based identity layer for travel, healthcare, and digital services, aiming to replace physical IDs with a secure, biometric link.

Read more on YOU